EP 3283086 A4 20190424 - METHOD AND SYSTEM FOR MICROBIOME-DERIVED DIAGNOSTICS AND THERAPEUTICS FOR CONDITIONS ASSOCIATED WITH MICROBIOME FUNCTIONAL FEATURES
Title (en)
METHOD AND SYSTEM FOR MICROBIOME-DERIVED DIAGNOSTICS AND THERAPEUTICS FOR CONDITIONS ASSOCIATED WITH MICROBIOME FUNCTIONAL FEATURES
Title (de)
VERFAHREN UND SYSTEM FÜR MIKROBIOM-DERIVIERTE DIAGNOSTIKA UND THERAPEUTIKA FÜR ERKRANKUNGEN IM ZUSAMMENHANG MIT MIKROBIOM-FUNKTIONSEIGENSCHAFTEN
Title (fr)
PROCÉDÉ ET SYSTÈME DE DIAGNOSTIC ET DE TRAITEMENT DÉRIVÉS DU MICROBIOME POUR DES PATHOLOGIES ASSOCIÉES AUX CARACTÉRISTIQUES FONCTIONNELLES DU MICROBIOME
Publication
Application
Priority
- US 201562146833 P 20150413
- US 201562147202 P 20150414
- US 201562147077 P 20150414
- US 201562147058 P 20150414
- US 201562147334 P 20150414
- US 2016027359 W 20160413
Abstract (en)
[origin: WO2016168354A1] A method for at least one of characterizing, diagnosing, and treating a condition associated with microbiome functional features in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the condition based upon features extracted from at least one of the microbiome composition dataset and the microbiome functional diversity dataset; based upon the characterization, generating a therapy model configured to correct the condition; and at an output device associated with the subject, promoting a therapy to the subject based upon the characterization and the therapy model.
IPC 8 full level
G16B 20/20 (2019.01); G16B 40/20 (2019.01); G16H 50/20 (2018.01); G16H 50/50 (2018.01); G16H 50/70 (2018.01); A61K 35/741 (2015.01); G16B 20/00 (2019.01)
CPC (source: EP US)
A61P 1/00 (2018.01 - EP); G16B 20/20 (2019.02 - EP US); G16B 40/00 (2019.02 - EP); G16B 40/20 (2019.02 - EP US); G16H 50/20 (2018.01 - EP); G16H 50/50 (2018.01 - EP); G16H 50/70 (2018.01 - EP); A61K 35/741 (2013.01 - EP); G16B 20/00 (2019.02 - EP US)
Citation (search report)
- [XY] WO 2014053608 A1 20140410 - METABOGEN AB [SE]
- [Y] US 2014065132 A1 20140306 - HSIAO ELAINE [US], et al
- [Y] WO 2015027116 A1 20150226 - UNIV CALIFORNIA [US]
Citation (examination)
- US 2013121968 A1 20130516 - QUAY STEVEN C [US]
- See also references of WO 2016168354A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2016168354 A1 20161020; AU 2016250104 A1 20171109; AU 2016250104 B2 20220210; CN 107708715 A 20180216; CN 107708715 B 20220603; EP 3283086 A1 20180221; EP 3283086 A4 20190424
DOCDB simple family (application)
US 2016027359 W 20160413; AU 2016250104 A 20160413; CN 201680033974 A 20160413; EP 16780670 A 20160413